Charles R St Hill
Overview
Explore the profile of Charles R St Hill including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
110
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
The role of FDG-PET-CT is limited in initial staging of nodal metastasis for thin cutaneous melanoma
Cheng D, McNicoll C, Kirgan D, Jones M, Rivera M, Doyle G, et al.
Am J Surg
. 2020 May;
221(4):737-740.
PMID: 32354604
Introduction: Positron emission tomography computed tomography (PET-CT) is often used to stage nodal metastases in thin cutaneous melanoma, with limited evidence. Methods: A retrospective review of patients with cutaneous malignant...
2.
Cheng D, Cross C, Calfee G, Kirgan D, Williams S, Baynosa J, et al.
Am J Surg
. 2019 Oct;
218(6):1052-1059.
PMID: 31619375
Background: Our objective is to explore differences in survival and treatment approaches for hepatocellular carcinoma (HCC) between academic centers (ACs) and non-academic centers (NACs), which may contribute to disparities in...
3.
Philips P, Li Y, Li S, St Hill C, Martin R
Mol Ther Methods Clin Dev
. 2015 Jun;
2:15001.
PMID: 26029712
Irreversible electroporation (IRE) is a promising cell membrane ablative modality for pancreatic cancer. There have been recent concerns regarding local recurrence and the potential use of IRE as a debulking...
4.
Miller A, St Hill C, Ellis S, Martin R
Am J Surg
. 2013 Jul;
206(4):443-50.
PMID: 23856086
Background: Few studies have evaluated the health-related quality-of-life (QOL) changes in patients following major liver resection for malignancy. Methods: QOL parameters were recorded prospectively at baseline (preoperative), and through 6 ...
5.
Kimbrough C, St Hill C, Martin R, McMasters K, Scoggins C
J Surg Oncol
. 2013 Mar;
107(6):602-7.
PMID: 23450687
Background: Resection margin status has been shown to impact outcomes for pancreatic adenocarcinoma (PAC), yet it remains unknown whether margin status is a reflection of tumor biology or surgical technique....
6.
Cannon R, Brown R, St Hill C, Dunki-Jacobs E, Martin 2nd R, McMasters K, et al.
Am Surg
. 2013 Jan;
79(1):35-9.
PMID: 23317602
There has been conflicting evidence regarding negative effects of blood transfusion in oncology patients. This study was undertaken to determine any negative effects of specific blood product transfusion after resection...
7.
Mbah N, Brown R, St Hill C, Bower M, Ellis S, Scoggins C, et al.
JOP
. 2012 Jul;
13(4):387-93.
PMID: 22797394
Context: Pancreatectomies for malignant and benign diseases are increasingly being performed worldwide. Recent studies, that have evaluated quality of life in pancreatectomy, have reported conflicting outcomes. Objective: This study was...
8.
Brown R, St Hill C, Greene Q, Farmer R, Reuter N, Callendar G, et al.
Am J Surg
. 2011 Oct;
202(6):748-52.
PMID: 22030405
Background: The current American Joint Committee on Cancer AJCC staging system applies to all soft-tissue sarcomas and does not allow for consideration of many features unique to retroperitoneal sarcomas (RPSs)....
9.
Egger M, Gilbert J, Burton A, McMasters K, Callender G, Quillo A, et al.
Am Surg
. 2011 Sep;
77(8):992-7.
PMID: 21944512
The prognostic significance of lymphovascular invasion (LVI) in melanoma remains controversial. Clinicopathologic data from a prospective trial of patients with melanoma were analyzed with respect to LVI. Disease-free survival and...
10.
St Hill C, Chagpar R, Callender G, Brown R, Gilbert J, Martin 2nd R, et al.
Ann Surg Oncol
. 2011 Jul;
19(1):139-44.
PMID: 21751045
Background: While several prognostic models have been developed to predict survival of patients who undergo hepatectomy for metastatic colorectal cancer (mCRC), few data exist to predict survival after recurrence. We...